Goldenwell Biotech, Inc. — Income Charts
1 years of history · ending 2024-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Income Breakdown
Revenue
$139
Cost of Revenue
$75
Gross Profit
$64
SG&A
—
Operating Income
$-123K
EBITDA
$-123K
Interest Expense
$8K
Other Income/Expense
$0
Pretax Income
$-131K
Tax Provision
$0
Net Income
$-131K
Gross Margin
46.0%
Operating Margin
-88559.7%
Net Margin
-94602.9%
Effective Tax Rate
0.0%
Deferred Tax Assets
$0
DTA Valuation Allowance
$286K
NOL Carryforwards
$1M
ETR Federal Statutory
21.0%
Operating Lease Cost
—
Revenue YoY Variation
-92.4%
Income YoY Variation
-6.3%